Aliases & Classifications for Dysphagia

MalaCards integrated aliases for Dysphagia:

Name: Dysphagia 53 29 54 6 32
Deglutition Disorders 71


External Ids:

ICD10 32 R13
UMLS 71 C0011168

Summaries for Dysphagia

NINDS : 53 Having trouble swallowing (dysphagia) is a symptom that accompanies a number of neurological disorders. The problem can occur at any stage of the normal swallowing process as food and liquid move from the mouth, down the back of the throat, through the esophagus and into the stomach. Difficulties can range from a total inability to swallow, to coughing or choking because the food or liquid is entering the windpipe, which is referred to as aspiration. When aspiration is frequent a person can be at risk of developing pneumonia. Food may get "stuck" in the throat or individuals may drool because they cannot swallow their saliva. Neurological conditions that can cause swallowing difficulties are: stroke (the most common cause of dysphagia); traumatic brain injury; cerebral palsy; Parkinson disease and other degenerative neurological disorders such as amyotrophic lateral sclerosis (ALS, also known as Lou Gehrig's disease), multiple sclerosis, progressive supranuclear palsy, Huntington disease, and myasthenia gravis. Muscular dystrophy and myotonic dystrophy are accompanied by dysphagia, which is also the cardinal symptom of oculopharyngeal muscular dystrophy, a rare, progressive genetic disorder.

MalaCards based summary : Dysphagia, also known as deglutition disorders, is related to chronic progressive external ophthalmoplegia and aspiration pneumonia, and has symptoms including seizures, vomiting and nausea and vomiting. An important gene associated with Dysphagia is ARID1B (AT-Rich Interaction Domain 1B). The drugs Levofloxacin and Moxifloxacin have been mentioned in the context of this disorder. Affiliated tissues include thyroid, tongue and brain, and related phenotypes are cellular and muscle

Wikipedia : 74 Dysphagia is difficulty in swallowing. Although classified under "symptoms and signs" in ICD-10, in some... more...

Related Diseases for Dysphagia

Diseases related to Dysphagia via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 999)
# Related Disease Score Top Affiliating Genes
1 chronic progressive external ophthalmoplegia 32.1 TWNK PIK3C2A
2 aspiration pneumonia 32.1 PIK3C2A PABPN1
3 leigh syndrome 31.0 TWNK COX15 COX10
4 myopathy 29.1 TWNK PIK3C2A PABPN1 MEGF10 COX10
5 mitochondrial myopathy 28.6 TWNK COX15 COX10
6 myopathy, areflexia, respiratory distress, and dysphagia, early-onset 12.8
7 odontoma-dysphagia syndrome 12.7
8 dysphagia lusoria 12.6
9 plummer vinson syndrome 12.3
10 opitz-gbbb syndrome 11.9
11 oculopharyngeal muscular dystrophy 11.7
12 opitz gbbb syndrome, type ii 11.7
13 swallowing disorders 11.7
14 amyotrophic lateral sclerosis 1 11.5
15 myasthenia gravis 11.5
16 supranuclear palsy, progressive, 1 11.4
17 jackhammer esophagus 11.4
18 diffuse idiopathic skeletal hyperostosis 11.4
19 esophagitis, eosinophilic, 1 11.4
20 aberrant subclavian artery 11.3
21 systemic scleroderma 11.3
22 esophageal tuberculosis 11.3
23 pseudobulbar palsy 11.3
24 niemann-pick disease, type c1 11.3
25 achalasia, familial esophageal 11.3
26 sjogren syndrome 11.3
27 spinal and bulbar muscular atrophy, x-linked 1 11.3
28 laryngeal tuberculosis 11.3
29 necrotizing autoimmune myopathy 11.3
30 arthrogryposis, distal, type 2a 11.3
31 spastic paraplegia 7, autosomal recessive 11.3
32 potocki-lupski syndrome 11.3
33 intestinal pseudo-obstruction 11.3
34 chronic inflammatory demyelinating polyradiculoneuropathy 11.3
35 corticobasal degeneration 11.3
36 thiamine metabolism dysfunction syndrome 2 11.2
37 striatonigral degeneration, infantile 11.2
38 central pontine myelinolysis 11.2
39 distal myopathy with vocal cord weakness 11.2
40 basal ganglia calcification, idiopathic, 1 11.1
41 cerebellar ataxia, areflexia, pes cavus, optic atrophy, and sensorineural hearing loss 11.1
42 spinocerebellar ataxia 13 11.1
43 neurodegeneration with brain iron accumulation 3 11.1
44 chromosome 1p36 deletion syndrome 11.1
45 mitochondrial dna depletion syndrome 4b 11.1
46 leukodystrophy, hypomyelinating, 15 11.1
47 biotin-thiamine-responsive basal ganglia disease 11.1
48 dyt-thap1 11.1
49 spinocerebellar ataxia 31 10.9
50 dystonia 12 10.9

Graphical network of the top 20 diseases related to Dysphagia:

Diseases related to Dysphagia

Symptoms & Phenotypes for Dysphagia

UMLS symptoms related to Dysphagia:

seizures, vomiting, nausea and vomiting, abdominal pain, constipation, headache, diarrhea, pseudobulbar signs, nausea, icterus, signs and symptoms, digestive, dyspepsia, heartburn, gastrointestinal gas, digestive system symptom, flatulence, eructation, and gas pain, symptoms involving digestive system, other symptoms involving digestive system, odynophagia, pain in esophagus (finding), absent deglutition, swallowing problems, choking sensation, symptom as reason for upper g.i. examination, dysphagia, pharyngeal phase, dysphagia, pharyngoesophageal phase

MGI Mouse Phenotypes related to Dysphagia:

# Description MGI Source Accession Score Top Affiliating Genes
1 cellular MP:0005384 9.43 COX10 COX15 MEGF10 PABPN1 PIK3C2A TWNK
2 muscle MP:0005369 8.92 ARID1B COX10 COX15 PABPN1

Drugs & Therapeutics for Dysphagia

Drugs for Dysphagia (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 347)
# Name Status Phase Clinical Trials Cas Number PubChem Id
Levofloxacin Approved, Investigational Phase 4 100986-85-4 149096
Moxifloxacin Approved, Investigational Phase 4 354812-41-2, 151096-09-2 152946
Ofloxacin Approved Phase 4 82419-36-1 4583
Tramadol Approved, Investigational Phase 4 27203-92-5 33741
Ketamine Approved, Vet_approved Phase 4 6740-88-1 3821
Lansoprazole Approved, Investigational Phase 4 103577-45-3 3883
Dexlansoprazole Approved, Investigational Phase 4 103577-45-3, 138530-94-6 9578005
Rabeprazole Approved, Investigational Phase 4 117976-89-3 5029
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 4 437-38-7 3345
Acetaminophen Approved Phase 4 103-90-2 1983
Remifentanil Approved Phase 4 132875-61-7 60815
Fluticasone Approved, Experimental Phase 4 90566-53-3 62924
Budesonide Approved Phase 4 51333-22-3 63006 5281004
Levobupivacaine Approved, Investigational Phase 4 27262-47-1 92253
Rocuronium Approved Phase 4 119302-91-9, 143558-00-3 441290
Isoflurane Approved, Vet_approved Phase 4 26675-46-7 3763
Cevimeline Approved Phase 4 107233-08-9 83898 25137844
Emtricitabine Approved, Investigational Phase 4 143491-57-0 60877
Cobicistat Approved Phase 4 1004316-88-4
Prednisone Approved, Vet_approved Phase 4 53-03-2 5865
Acetylcholine Approved, Investigational Phase 4 51-84-3 187
Prednisolone phosphate Approved, Vet_approved Phase 4 302-25-0
Methylprednisolone Approved, Vet_approved Phase 4 83-43-2 6741
Methylprednisolone hemisuccinate Approved Phase 4 2921-57-5
Prednisolone Approved, Vet_approved Phase 4 50-24-8 5755
26 Prednisolone acetate Approved, Vet_approved Phase 4 52-21-1
Lisinopril Approved, Investigational Phase 4 76547-98-3, 83915-83-7 5362119
Fluorouracil Approved Phase 4 51-21-8 3385
Cetuximab Approved Phase 4 205923-56-4 56842117 2333
Oxycodone Approved, Illicit, Investigational Phase 4 76-42-6 5284603
31 Mosapride Investigational Phase 4 112885-41-3
Tenofovir Experimental, Investigational Phase 4 147127-20-6 464205
Prednisolone hemisuccinate Experimental Phase 4 2920-86-7
34 Norgestimate, ethinyl estradiol drug combination Phase 4
35 Excitatory Amino Acid Antagonists Phase 4
36 Anesthetics, Dissociative Phase 4
37 Cytochrome P-450 Enzyme Inhibitors Phase 4
38 Hormones Phase 4
39 Hormone Antagonists Phase 4
40 Dermatologic Agents Phase 4
41 Serotonin Receptor Agonists Phase 4
42 Carboxymethylcellulose Sodium Phase 4
43 Respiratory System Agents Phase 4
44 Bronchodilator Agents Phase 4
45 Anti-Asthmatic Agents Phase 4
46 Antipyretics Phase 4
47 Antiviral Agents Phase 4
48 Anti-Infective Agents Phase 4
49 Anti-Allergic Agents Phase 4
50 Soy Bean Phase 4

Interventional clinical trials:

(show top 50) (show all 823)
# Name Status NCT ID Phase Drugs
1 Comparation the Effect of C-LMA and I-gel in Regurgitation and Postoperative Complications Unknown status NCT01876836 Phase 4
2 Personalized Peroral Endoscopic Myotomy for Achalasia Unknown status NCT01570621 Phase 4
3 Multi-Centre, Prospective, Open Label, Randomized Trial to Assess the Efficacy and Safety of Moxifloxacin Versus Levofloxacin Plus Metronidazole in the Treatment of Community-Acquired Pneumonia With Aspiration Factors Unknown status NCT00752947 Phase 4 moxifloxacin;levofloxacin;metronidazole
4 A Randomized Study on the Effects of Lactobacillus Brevis CD2 in the Prevention of Radio and Chemotherapy Induced Oral Mucositis in Head and Neck Cancer Patients. Unknown status NCT01707641 Phase 4
5 Endoesophageal Cryotherapy: A New Technique For Ablating Barrett's Esophagus And Early Stage Esophageal Cancer Unknown status NCT00628784 Phase 4
6 Effectiveness of Low Level Laser at the Auriculotherapy Points, in Reducing Postoperative Pain in Third Molar Surgery Unknown status NCT02657174 Phase 4
7 Comparison of Effect of Peritonsillar Infiltration of Ketamine and Tramadol on Pediatric Posttonsillectomy Pain: A Double-blinded Randomized Placebo-controlled Clinical Trial Unknown status NCT03067103 Phase 4 Tramadol;Ketamine;Placebos
8 Effect of Pharyngeal Inhibition Induced by Repetitive Transcranial Stimulation in Post Stroke Dysphagia Completed NCT01081444 Phase 4
9 Neuromuscular Electroestimulation and Respiratory Muscle Training in the Management of Dysphagia of Subacute Stroke Patients Completed NCT02473432 Phase 4
10 Pediatric Dysphagia Outcomes After Injection Laryngoplasty for Type I Laryngeal Cleft Completed NCT01507207 Phase 4
11 Evaluation of Two Different Thickening Products in Patients With Dysphagia Completed NCT01651975 Phase 4
12 Efficacy of IV vs Oral Administration of Acetaminophen for Pain Control Following Tonsillectomy With or Without Adenoidectomy Completed NCT01721486 Phase 4 IV acetaminophen;PO acetaminophen
13 Does Opioid Induced Swallowing Difficulty Lead to Elevated Risk for Pulmonary Aspiration? Completed NCT01495377 Phase 4 Remifentanil;Placebo;Technetium
14 Peritonsillar Infiltration With Levobupivacaine for Relief of Posttonsillectomy Pain: Does Concentration Have Any Effect? Completed NCT02322346 Phase 4 Group LL;Group HL
15 Face-to-face Tracheal Intubation With Fastrach or Videolaryngoscopes Completed NCT02286570 Phase 4
16 Blind Intubation Through The Self-Pressurised Disposable Air-Q Laryngeal Intubation Mask: An International Multicentre Trial Completed NCT01906060 Phase 4
17 Role of Mosapride in Patients With Gastroesophageal Reflux Disease Completed NCT00729339 Phase 4 mosapride for the first month and placebo for the 2nd month;placebo for the first and mosapride for the second month
18 Comparing Hemodynamic Changes for Intubation With Shikani Intubating Stylet and Macintosh Laryngoscope Completed NCT01271543 Phase 4
19 An Investigator-Initiated,Multicenter,Randomized,Double-Blind Placebo-Controlled Design Study to Assess the Effectiveness of CeviMeline to Improve OraL Health in Patients With XErostomia Secondary to Radiation Therapy for Treatment of Head and Neck Squamous Cell Carcinoma Completed NCT00466388 Phase 4 Cevimeline
20 Do Laryngeal Biopsy Findings Predict Treatment Response in Suspected Laryngopharyngeal Reflux Completed NCT00444145 Phase 4 Prevacid
21 Role of Esophageal and Laryngeal Biopsies in Suspected Laryngopharyngeal Reflux Completed NCT00373997 Phase 4
23 Effect of Laryngeal Mask Cuff Pressure on Postoperative Pharyngolaryngeal Complications in Geriatric Patients Completed NCT02189954 Phase 4
24 Comparison of Storz C-MAC and D-MAC Orotracheal Intubation Systems in Morbidly Obese Patients - A Prospective Randomized Crossover Trial Completed NCT01556061 Phase 4
25 The Influence of CYP2C19 Genetic Polymorphism and Dosage of Rabeprazole on the Accuracy of Proton-Pump Inhibitor Testing in Chinese Patients With Gastroesophageal Reflux Disease Completed NCT00354757 Phase 4 rabeprazole
26 The Effect of Corticotrophin-releasing Hormone (CRH) on Esophageal Motility in Healthy Volunteers Completed NCT02736734 Phase 4 CRH
27 Analysis of Crushed and Whole Tablet Genvoya Completed NCT03717129 Phase 4 Genvoya Oral dose;Genvoya Crushed Dose
28 Impact of Single Dose Perioperative Steroids on Dysphagia Following Anterior Cervical Spine Surgery: A Randomized, Prospective, Double-Blind Study Recruiting NCT03711474 Phase 4 Dexamethasone;Saline
29 A Pilot Study Assessing the Efficacy of Steroids in the Treatment of Achalasia Enrolling by invitation NCT01903486 Phase 4 Apo-Prednisone Cordorol, Detasone - Prednisone
30 Botulinum Toxin Pyloroplasty to Reduce Postoperative Nausea and Vomiting After Sleeve Gastrectomy Enrolling by invitation NCT03701919 Phase 4 Botulinum toxin pyloroplasty;Normal saline pyloric injection
31 Reduction in Symptomatic Oesophageal Stricture Formation Post-two Stage Complete Barrett's Excision for High Grade Dysplasia or Early Adenocarcinoma With Short-term Steroid Therapy: A Randomized, Doubleblind, Placebo-controlled, Multicentre Trial. Not yet recruiting NCT02004782 Phase 4 Prednisolone;Placebo Oral Tablet
32 A Randomized Placebo Controlled Trial of Low Dose Angiotensin Converting Enzyme Inhibitor to Prevent Pneumonia in Older People Who Require Tube Feeding Because of Neurological Dysphagia Terminated NCT02358642 Phase 4 Angiotensin converting enzyme inhibitor (Lisinopril);Placebo
33 Use of Xtampza ER to Overcome Difficulties in Swallowing Opioid Pills Terminated NCT03588806 Phase 4 Xtampza ER (oxycodone)
34 Randomized Phase IV Trial to Compare Cetuximab With Concomitant Radiation Therapy With Concomitant Mitomycin-C and 5-Fluorouracil With Radiation Therapy for Locally Advanced Squamous Cell Carcinomas of the Head and Neck Terminated NCT02015650 Phase 4 Cetuximab;Mitomycin-C/ 5-Fluorouracil
35 Randomized, Prospective, Double-blind Trial of PPI vs Placebo in Prevention of Gastrojejunal Strictures After Laparoscopic Roux-en-Y Gastric Bypass for Morbid Obesity Withdrawn NCT00361985 Phase 4 Esomeprazole;Esomeprazole
36 The Comparison of Value of Brachytherapy and Endoscopic Stenting With SEMS in Palliative Treatment of Dysphagia Resulting From Adenocarcinoma of the Esophago-Gastric Junction Unknown status NCT01786278 Phase 2, Phase 3
37 Impact of Early Percutaneous Tracheostomy on the Incidence of Swallowing Dysfunction in Critically Ill Patients on Mechanical Ventilation. A Randomized Clinical Trial Unknown status NCT01268423 Phase 3
38 Self-Expandable Esophageal Radiation Stent:a Multicentric Randomized Controlled Trial in Patients With Advanced Esophageal Cancer Unknown status NCT01054274 Phase 3
39 Predicting Oral Care Before Percutaneous Endoscopic Gastrostomy (PEG). The Influence of Oral Hygiene on Local Wound and Systemic Infection in Patients With PEG Placement Unknown status NCT00859235 Phase 3 Chlorhexidine gluconate 0.2%
40 Prospective Randomized Phase III Study of Laparoscopic Lightweight Mesh Repair of Large Hiatal Hernias Unknown status NCT01408108 Phase 3
41 Prospective Randomized Phase III Study of Laparoscopic Repair of Giant Hiatal Hernias With Nitinol-framed Lightweight Polytetrafluoroethylene Mesh Unknown status NCT01780285 Phase 3
42 Comparative Study Between the Effect of Diclofanic and Ketorolac in Post Tonsillectomy Pain Management Unknown status NCT03178539 Phase 2, Phase 3 diclofenac;ketorolac
43 RIVA-PSP: Efficacy of Rivastigmine on Motor, Cognitive and Behavioural Impairment in Progressive Supranuclear Palsy: A Randomised Double Blind Placebo-controlled Clinical Trial Unknown status NCT02839642 Phase 3 Rivastigmine;Placebo
44 The Influence of Glutamine on the Side Effects of Chemo-radiation in Head and Neck Cancer Patients - A Randomized Controlled Trial Unknown status NCT02282839 Phase 3
45 A Prospective Randomized Trial Comparing Laparoscopic Nissen Against Anterior Partial Fundoplication in Treating Gastroesophageal Reflux Disease Among Chinese Patients Unknown status NCT00480285 Phase 3
46 Efficacy and Cost Efficacy of Prophylactic Treatment With Antibiotics During Concomitant Chemoradiotherapy in Patients With Locally Advanced Head and Neck Cancer to Prevent Aspiration Pneumonia. A Randomized Phase II-III Study Unknown status NCT01598402 Phase 2, Phase 3 amoxicillin/clavulanic acid suspension
47 A Randomised Controlled Trial of Dysphagia Therapies for Swallowing Disorders Following Stroke. Completed NCT00257764 Phase 2, Phase 3
48 A Randomized, Prospective Trial of Electrosurgical Incision Followed by Rabeprazole Versus Bougie Dilation Followed by Rabeprazole of Symptomatic Lower Esophageal (Schatzki's) Rings Completed NCT00204750 Phase 2, Phase 3
49 Study for the Evaluation of the Impact of HEPILOR on the Possible Delay in the Development of Dysphagia in Breast Cancer Patients Undergoing Adjuvant Radiotherapy on the Breast/Thoracic Wall and Lymph Node Drainage. Completed NCT03997188 Phase 3
50 A Randomized Controlled Trial of NMES vs. Traditional Dysphagia Therapy After Stroke Completed NCT01279824 Phase 2, Phase 3

Search NIH Clinical Center for Dysphagia

Genetic Tests for Dysphagia

Genetic tests related to Dysphagia:

# Genetic test Affiliating Genes
1 Dysphagia 29

Anatomical Context for Dysphagia

MalaCards organs/tissues related to Dysphagia:

Thyroid, Tongue, Brain, Lung, Testes, Bone, Breast

Publications for Dysphagia

Articles related to Dysphagia:

(show top 50) (show all 27238)
# Title Authors PMID Year
A de novo PABPN1 germline mutation in a patient with oculopharyngeal muscular dystrophy. 61 54
16481821 2006
Oculopharyngeal muscular dystrophy with PABPN1 mutation in a Chinese Malaysian woman. 61 54
15725589 2005
[Oculopharyngeal muscular dystrophy: study of patients from seven Spanish families with different GCG expansions in PABP2 gene]. 61 54
15150706 2004
Spinocerebellar ataxia type 1 (SCA1): phenotype-genotype correlation studies in intermediate alleles. 61 54
11973625 2002
[The clinical characters of myopatic pharyngoparalysis and laryngoparalysis with 3 cases report]. 54 61
12563974 1999
Oculopharyngeal muscular dystrophy: non-French-Canadian pedigrees. 61 54
9585341 1998
Autosomal dominant cerebellar ataxia type I clinical features and MRI in families with SCA1, SCA2 and SCA3. 61 54
8931575 1996
Environmental surveillance and adverse neonatal health outcomes in foals born near unconventional natural gas development activity. 61
32434096 2020
Mediastinal malignant mesothelioma discovered in a patient with dysphagia. 61
32528683 2020
König's Syndrome After Roux-en-Y Gastric Bypass: Candy Cane Twist. 61
32377990 2020
The effects of acetylcholinesterase inhibitors on morbidity after general anesthesia and surgery. 61
32416089 2020
Effect of Laryngeal Suspension and Upper Esophageal Sphincter Myotomy for Severe Dysphagia Due to Brainstem Disease. 61
32037848 2020
The modified DYMUS questionnaire is a reliable, valid and easy-to-use tool in the assessment of dysphagia in multiple sclerosis. 61
32180320 2020
Opioid-induced esophageal dysfunction. 61
32427604 2020
Aberrant subclavian artery division and revascularization by a supraclavicular approach for definitive or staged treatment of dysphagia lusoria. 61
31831313 2020
Cricoid Chondronecrosis: Case Report and Review of Literature. 61
32070112 2020
Dysphagia: A review. 61
32568790 2020
Dysphagia: A review. 61
32568791 2020
The Gugging Swallowing Screen in dysphagia screening for patients with stroke: A systematic review. 61
32408200 2020
Co-occurring medical conditions in adults with Down syndrome: A systematic review toward the development of health care guidelines. Part II. 61
32338447 2020
CHARGE syndrome associated with de novo (I1460Rfs*15) frameshift mutation of CHD7 gene in a patient with arteria lusoria and horseshoe kidney. 61
32509017 2020
Failure to bictegravir and development of resistance mutations in an antiretroviral-experienced patient. 61
31982483 2020
Impedance and Histologic Characteristics of the Sub-Laryngeal Esophagus Distinguish Eosinophilic Esophagitis From Other Esophageal Disorders. 61
31589979 2020
14 Years' experience of esophageal replacement surgeries. 61
32236666 2020
Endoscopy-assisted, transoral submucosal coblation for pediatric retropharyngeal lymphatic malformations. 61
32416530 2020
Survival Comparision of Three-dimensional Radiotherapy Alone vs. Chemoradiotherapy for Esophageal Squamous Cell Carcinoma. 61
32418649 2020
Functional Outcomes Regarding Facial Artery Musculomucosal Flap for Reconstruction of Partial Glossectomy Defects. 61
32187069 2020
Third-time ("redo-redo") anti-reflux surgery: patient-reported outcomes after a thoracoabdominal approach. 61
31388809 2020
Short- and long-term results after laparoscopic floppy Nissen fundoplication in elderly versus non-elderly patients. 61
31031314 2020
Magnetic Sphincter Augmentation Superior to Proton Pump Inhibitors for Regurgitation in a 1-Year Randomized Trial. 61
31518717 2020
Definitive re-irradiation of locally recurrent esophageal cancer after trimodality therapy in patients with a poor performance status. 61
32454972 2020
Microvascular decompression for hemifacial spasm associated with distinct offending vessels: A retrospective clinical study. 61
32413816 2020
Immediate Voice and Swallowing Complaints Following Revision Anterior Cervical Spine Surgery. 61
32482158 2020
Predicting Airway Invasion Using Screening Tools and Laryngeal Kinematics in People with Parkinson's Disease: A Pilot Study. 61
32538868 2020
Clinical Challenges and Images in GI An unusual cause of dysphagia. 61
32504639 2020
Interventions for oropharyngeal dysphagia in acute and critical care: a systematic review and meta-analysis. 61
32514597 2020
Validity and reliability of a French version of M.D. Anderson Dysphagia Inventory. 61
32488380 2020
Effect of Different Frequencies of Electroacupuncture on Post-Stroke Dysphagia in Mice. 61
32519209 2020
Role of Bilateral Corticobulbar Tracts in Dysphagia after Middle Cerebral Artery Stroke. 61
32524719 2020
Risk factors for dysphagia in ICU patients following invasive mechanical ventilation. 61
32525018 2020
Swallowing Outcomes and Discharge Destinations in Acute Stroke Tube-Feeding Dependent Dysphagia Patients Treated With Neuromuscular Electrical Stimulation During Inpatient Rehabilitation. 61
31764228 2020
Anodal transcranial direct current stimulation and intermittent theta-burst stimulation improve deglutition and swallowing reproducibility in elderly patients with dysphagia: A methodological issue to avoid misinterpretation. 61
32515110 2020
Influence of radiation dose to pharyngeal constrictor muscles on late dysphagia and quality of life in patients with locally advanced oropharyngeal carcinoma. 61
32006068 2020
Validity and reliability of the MD Anderson dysphagia inventory in English and Chinese in head and neck cancer patients. 61
32573112 2020
A randomized clinical trial on the acute therapeutic effect of TRPA1 and TRPM8 agonists in patients with oropharyngeal dysphagia. 61
32064725 2020
Dysphagia is associated with poor physical function in patients with acute heart failure: a prospective cohort study. 61
31368089 2020
Effect of dysphagia rehabilitation in patients receiving enteral nutrition at home nursing care: a retrospective cohort study. 61
32506544 2020
Hyoid position as a novel predictive marker for postoperative dysphagia and dysphonia after anterior cervical discectomy and fusion. 61
32507917 2020
Implementation Strategies for the International Dysphagia Diet Standardisation Initiative (IDDSI), Part I: Quantitative Analysis of IDDSI Performance Among Varied Participants. 61
32510986 2020
Excessive daytime sleepiness and dysphagia in Parkinson's disease, from the assessment of a risk to a pathophysiological landscape. 61
32417041 2020

Variations for Dysphagia

ClinVar genetic disease variations for Dysphagia:

6 ‎‎ ‎‎ ‎‎ ‎‎
# Gene Name Type Significance ClinVarId dbSNP ID GRCh37 Pos GRCh38 Pos
1 ARID1B NM_020732.3(ARID1B):c.5968C>T (p.Arg1990Ter)SNV Pathogenic 210306 rs797045283 6:157528243-157528243 6:157207109-157207109
2 ZGRF1 NM_001350397.1(ZGRF1):c.3420_3421CT[1] (p.Ser1141fs)short repeat Uncertain significance 374091 rs1057518892 4:113508616-113508617 4:112587460-112587461
3 DNMT1 NM_001130823.3(DNMT1):c.2718C>G (p.Phe906Leu)SNV Uncertain significance 373927 rs1057518774 19:10259562-10259562 19:10148886-10148886
4 SLC6A3 NM_001044.5(SLC6A3):c.1139_1150del (p.Gly380_Lys384delinsGlu)deletion Uncertain significance 692102 5:1414812-1414823 5:1414697-1414708

Expression for Dysphagia

Search GEO for disease gene expression data for Dysphagia.

Pathways for Dysphagia

GO Terms for Dysphagia

Cellular components related to Dysphagia according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 cytochrome complex GO:0070069 8.62 COX15 COX10

Biological processes related to Dysphagia according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 proton transmembrane transport GO:1902600 9.4 COX15 COX10
2 mitochondrion organization GO:0007005 9.37 TWNK COX10
3 heme biosynthetic process GO:0006783 9.32 COX15 COX10
4 mitochondrial electron transport, cytochrome c to oxygen GO:0006123 9.26 COX15 COX10
5 cellular respiration GO:0045333 9.16 COX15 COX10
6 respiratory chain complex IV assembly GO:0008535 8.96 COX15 COX10
7 heme a biosynthetic process GO:0006784 8.62 COX15 COX10

Molecular functions related to Dysphagia according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 cytochrome-c oxidase activity GO:0004129 8.62 COX15 COX10

Sources for Dysphagia

9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
31 HPO
32 ICD10
33 ICD10 via Orphanet
37 LifeMap
41 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
54 Novoseek
57 OMIM via Orphanet
61 PubMed
70 Tocris
72 UMLS via Orphanet
Loading form....